Associations between antiretroviral regimen and changes in blood pressure: results from the D2EFT study.
Clin Infect Dis
; 2024 May 09.
Article
em En
| MEDLINE
| ID: mdl-38721980
ABSTRACT
In this randomised, controlled study in 14 low- and middle-income countries, individuals taking dolutegravir with darunavir/ritonavir for 48 weeks had a greater increase in systolic and diastolic blood pressure than individuals taking two nucleoside reverse transcriptase with darunavir/ritonavir. The difference remained significant after controlling for confounding factors including weight gain.
Texto completo:
1
Bases de dados:
MEDLINE
Idioma:
En
Revista:
Clin Infect Dis
Assunto da revista:
DOENCAS TRANSMISSIVEIS
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Austrália